XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (16776)	4/9/2004 1:01:25 AM
From: Bluegreen	of 17367

FINALLY, I got THROUGH to YOU!!!!!!!! That is why I kept TOUTING COMPETITION!!!!!!!!!! Listen, there is AT LEAST 500,000 patients needing BIOLOGICS for moderate to severe Psoriasis for LIFETIME treatment. And this is just in the USA!!!! Since NO single Biologic treatment works for everyone THEN thank goodness for patients and the BIOLOGICAL industry that combos will be available!!!!!!!!!! I am going to be VERY excited to see what happens if physicians start adding Raptiva off label to Enbrel for treatment of Rheumatoid arthritis. Think of how Raptiva or Enbrel could be added to Amevive!!!!! This is JUST THE BEGINNING!!!!!!! Healthy competition is ALWAYS a GOOD thing!!!! BTW, how about off label usage of Biologics for mild Psoriasis????? Before you talk about EXPENSE, think how much people spend nowadays on BOTOX and laser skin treatments!!!!!! ONE last point, REMEMBER it was GENENTECH that got those 80% biologic naive in the front door.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next